An Israeli founder preparing for a Pentagon demonstration knows what the first questions will be. How long does it take to train a soldier? What went wrong the first time an Israeli unit used the equipment? She will have rehearsed those answers before she boards the plane. The question I would urge her to take to Washington is this: If this trial goes well, what decision will it allow you to make?
Consider what happens when an American officer likes the equipment and asks for a change. From his perspective, the trial has done its job. His soldiers have found something worth improving, and he has explained what they need. At a startup in Israel, that conversation sets off a different calculation. Suppose the change will occupy four engineers for three months. At a company with twelve employees, the founder is committing a third of her workforce for a quarter. What should she tell the customer whose work she has to postpone?
Israeli founders have something valuable to bring to that conversation. An engineer who took a call from a soldier when a system broke knows how long the unit went without it. She knows whether the soldier fixed it with a spare part or waited for someone from the company to arrive. That is what gives the words "field tested" their value. It also gives an American buyer a question to open with. If the same part breaks at a base in North Carolina on a Friday afternoon, who sends the replacement?
For a founder in Tel Aviv, the answer has consequences beyond the demonstration. Keeping spare parts in America ties up cash. Hiring a service partner changes the price she needs to charge. If she learns those things early, she has time to work out whether the sale makes sense. Learn them after quoting a price for five hundred units, and her first American order risks becoming the most expensive mistake in the company's history.
The Pentagon has a set of figures on this subject. In 2025, the US Government Accountability Office reviewed the Defense Innovation Unit, which helps the military adopt commercial technology. Through fiscal 2023, DIU reported that 51 percent of its projects with at least one completed prototype agreement had advanced to a production award or contract. There is no ideal percentage here. A trial that exposes an expensive flaw is money well spent. What matters to the founder is knowing which question the trial was meant to answer and whether the results answered it.
As an investor, I would finance six months of work to find out whether American soldiers are able to maintain a system without the engineers who built it. Even if the order falls through, the founder learns something she needs to know about every overseas sale. I would look harder at a request to finance a fourth demonstration. Who will be in the room this time? What do they need to see that the first three audiences missed?
Israel and the United States should bring the prospective buyer into the planning of any joint trial meant to inform a purchase. The soldiers using the equipment should decide what good performance looks like in the field. The official considering an order should explain what evidence would support it and when funding is due for review. Sometimes the answer will be that the service has no money available this year. An Israeli company with nine months of cash left is better off hearing that in February than in October.
There is an American interest here, too. A purchasing process that assumes every bidder has the resources to spend a year answering further questions favors the large incumbents already doing business with the Pentagon. Bringing the buyer in early gives a small supplier a reason to stay in the competition. It gives the military a chance to learn whether the engineers behind a prototype are ready to support the people who will depend on it.
At the next demonstration, I would leave the last ten minutes to the soldier, the buyer and the founder. Once the equipment is packed away, they have one question worth answering. What would it take to put this into service?